Exploring Milkyway Chemical Supply Chain Service Co., Ltd. Investor Profile: Who’s Buying and Why?

Exploring Milkyway Chemical Supply Chain Service Co., Ltd. Investor Profile: Who’s Buying and Why?

CN | Industrials | Integrated Freight & Logistics | SHH

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Who is quietly reshaping the chemical logistics landscape and why are they buying Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS)? With a striking 24.26% revenue jump to CNY 12.12 billion in 2024 and a net income of CNY 565 million (up 31.04%), Milkyway has drawn in a mix of institutional investors, insiders and strategic partners-backed by a market capitalization near CNY 8.29 billion and 158.13 million shares outstanding-while institutions already control about 31.01% and insiders hold roughly 40.65%, signaling concentrated confidence; major moves like the CNY 118 million ExxonMobil logistics contract, a SGD 38 million Singapore acquisition, and roughly $10 million in R&D investment have provoked short-term share reactions (a 2.7% dip on the Exxon tie and a 2.3% slide after the Singapore deal) but also sparked debate among investors about growth, governance and market expansion-read on to unpack who the key buyers are, what they stand to gain, and how these hard numbers shape Milkyway's investor profile

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) - Who Invests in Milkyway Chemical Supply Chain Service Co., Ltd. and Why?

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) attracts a mix of institutional investors, retail shareholders, and strategic partners drawn by its strong 2024 operating performance, targeted expansion, and industry-specific capabilities.
  • Revenue growth: 24.26% in 2024, reaching CNY 12.12 billion.
  • Net income: CNY 565 million in 2024, up 31.04% year-over-year.
  • R&D commitment: approx. $10 million invested in new chemical formulations and supply-chain technologies.
  • Strategic inorganic expansion: acquisition of a Singaporean chemical logistics firm for SGD 38 million to extend Southeast Asian footprint.
  • Major commercial partnerships: a contract with ExxonMobil for logistics and warehousing at the Huizhou plant worth ~CNY 118 million.
Investor Type Primary Motivations Representative Metrics / Deals
Institutional Investors (funds, asset managers) Seek scalable, high-margin logistics exposure; income plus capital appreciation; corporate governance and reporting standards. 2024 revenue CNY 12.12B; net income CNY 565M; steady EBITDA expansion.
Individual Shareholders Attracted to consistent growth trajectory, dividend potential, and sector specialization (chemical logistics). Share-price catalysts: overseas acquisition (SGD 38M) and recurring large contracts (e.g., CNY 118M ExxonMobil).
Strategic Partners (oil & chemical majors, distributors) Secure reliable, compliant logistics and warehousing; reduce supply-chain risk; co-develop tailored services. ExxonMobil Huizhou contract ≈ CNY 118M; bespoke logistics solutions; R&D collaboration potential.
  • Why institutions increase allocations: double-digit revenue and net-income growth in 2024, scalable Southeast Asia expansion, and quantifiable contract backlog.
  • Why individuals buy: visible growth story, clear service differentiation in hazardous/chemical logistics, and potential dividend upside driven by rising net income.
  • Why strategic partners engage: Milkyway's technical capabilities, specialized warehousing, and demonstrated contract value with global oil/chemical players.
For a broader corporate context and ownership background see: Milkyway Chemical Supply Chain Service Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) Institutional Ownership and Major Shareholders of Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS)

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) displays a concentrated ownership structure driven by significant insider holdings and a meaningful institutional stake. As of late 2025 the company has a market capitalization of approximately CNY 8.29 billion with 158.13 million shares outstanding. Institutional investors control roughly 31.01% of the shares while insiders (executives, employees and related parties) hold about 40.65%. The remaining free-float is held by retail investors and the public, supporting liquidity and secondary-market activity.
  • Market capitalization: CNY 8.29 billion (late 2025)
  • Shares outstanding: 158.13 million
  • Institutional ownership: 31.01%
  • Insider ownership: 40.65%
  • Public/retail free-float: ~28.34%
Metric Value
Market Capitalization (CNY) 8,290,000,000
Shares Outstanding 158,130,000
Institutional Ownership 31.01%
Insider Ownership 40.65%
Public/Retail Ownership 28.34%
Key implications of this ownership mix:
  • Concentrated insider ownership aligns executive incentives with long-term value creation but can limit minority influence on strategic decisions.
  • Institutional holding at ~31% signals professional investor confidence and offers monitoring discipline-these investors often demand transparency around M&A, capital allocation and margin improvement.
  • Relatively lower free-float compared with many peers can increase share-price volatility on flows and news events, while also amplifying the impact of large institutional trades.
  • Major shareholders closely monitor strategic initiatives (acquisitions, partnerships, capital expenditure) for EPS accretion, ROE improvement and cash-conversion impacts.
Investor types and motivations driving current buying activity:
  • Long-only institutions: seeking exposure to China chemical logistics/SCM growth, recurring revenue from contract logistics and margin expansion through scale.
  • Strategic/industry investors: attracted by upstream/downstream integration potential and synergies from partnerships or targeted acquisitions.
  • Insider accumulation: management and employee shareholding reflects confidence in executing the business model and participating in upside from strategic initiatives.
  • Retail investors: trading on momentum, valuation, and company-specific news; provide day-to-day liquidity but less strategic engagement.
Major shareholders focus areas when assessing Milkyway:
  • Profitability metrics: gross margin trends, operating margin, and EBITDA conversion.
  • Balance sheet strength: leverage ratios, net debt/EBITDA, and working-capital management.
  • Return metrics: ROE and ROIC trajectories post-acquisition or partnership.
  • Capital allocation: dividend policy, buyback potential, and use of cash for strategic M&A.
  • Governance and disclosure: board composition, minority protections, and transparency in related-party transactions.
For granular financial context and how shareholder expectations map to Milkyway's operating performance see Breaking Down Milkyway Chemical Supply Chain Service Co., Ltd. Financial Health: Key Insights for Investors

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) - Key Investors and Their Impact on Milkyway Chemical Supply Chain Service Co., Ltd.

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) has attracted a diversified investor base - strategic corporate partners, institutional investors, and insiders - each shaping the company's capital allocation, growth trajectory and risk profile. Recent material transactions and partnerships illustrate why various investor groups are committing capital and how their influence translates into operational and financial outcomes.
  • Strategic corporate partnership: ExxonMobil logistics contract at Huizhou (~CNY 118 million) demonstrates capability to execute large-scale, high-compliance chemical logistics projects, de-risking revenue for risk-averse strategic and sovereign investors.
  • Cross-border expansion: Acquisition of a Singaporean chemical logistics firm for SGD 38 million expands Southeast Asian footprint and attracts regional PE and corporate investors seeking exposure to integrated China-ASEAN logistics flows.
  • Institutional capital: Mutual funds, asset managers and sovereign wealth allocations are driven by Milkyway's revenue growth, margin expansion and recurring-contract profile, providing low-cost capital for capex and M&A.
  • Insider ownership: Material holdings by executives and employees align incentives, improve governance perceptions, and often reduce stock volatility post-deal announcements.
Investor Type Representative Stake / Ticket Size Primary Motivation Impact on Milkyway
Strategic corporate (e.g., ExxonMobil) Contract value CNY 118,000,000 (logistics & warehousing) Secure specialized logistics capacity; operational reliability Stable, high-margin contract revenue; reference client for new business
Regional strategic/Corporate M&A Acquisition: SGD 38,000,000 (Singapore firm) Market access to Southeast Asia; integrated service offerings Geographic diversification; incremental revenue streams; cross-selling
Institutional investors (mutual funds, asset managers) Typical holdings: 5-15% aggregate in public float (varies) Growth and free-cash-flow generation; sector consolidation play Provides capital for expansion, supports share liquidity and valuation
Insiders (executives & employees) Significant combined stake (often double-digit as % of management-owned shares) Alignment of long-term performance incentives Governance stability; long-horizon decision-making
Key investor-driven considerations investors evaluate when backing Milkyway:
  • Contract pipeline quality and counterparty credit (e.g., multinational clients like ExxonMobil).
  • Return on deployed capital for M&A (measured by incremental EBITDA and payback from acquisitions such as the SGD 38M purchase).
  • Regulatory and compliance track record in hazardous materials handling and cross-border operations.
  • Management equity alignment and insider lock-up structures that preserve long-term orientation.
Financial and operational signals that have attracted investor interest:
  • Large-scale contract wins (CNY 118M ExxonMobil engagement) boosting revenue visibility for multiple quarters.
  • Strategic inorganic growth (SGD 38M Singapore acquisition) expected to lift regional revenues and utilization rates.
  • Improving margins from scale in warehousing, integrated logistics and value-added chemical supply chain services.
  • Capital raised or redeployed via institutional financing to support capex, technology upgrades, and cross-border integrations.
Investor expectations and evaluation metrics commonly cited by buy-side participants:
  • Revenue CAGR and margin expansion trajectories post-acquisition.
  • EBITDA contribution and synergies realization schedule from the SGD 38M acquisition.
  • Contract renewal rates and counterparty concentration following large contracts such as the CNY 118M ExxonMobil agreement.
  • Insider share disposition plans and any tranche-based incentive unlocks impacting free float.
For context on corporate mission alignment and investor-facing messaging, Milkyway's public positioning and long-term goals can be reviewed here: Mission Statement, Vision, & Core Values (2026) of Milkyway Chemical Supply Chain Service Co., Ltd.

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) - Market Impact and Investor Sentiment

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) has experienced event-driven volatility in its share price while underlying financials and strategic initiatives have supported a constructive longer-term investor view.
  • June 2023 acquisition of a Singaporean chemical logistics firm for SGD 38 million triggered a 2.3% share-price decline, reflecting immediate market skepticism about integration risks and near-term cash outflow impact.
  • April 2023 partnership with ExxonMobil led to a 2.7% share-price drop, signalling investor concern over contractual margins, operational execution and potential capital/resource demands tied to the new agreement.
  • Despite those short-term reactions, investors remain attracted to Milkyway's growth trajectory driven by acquisitions, partnerships and targeted R&D investments.
  • Reported financial performance for 2024 shows a 24.26% year-over-year revenue increase and net income of CNY 565 million, metrics that have reinforced investor confidence in the company's profitability and cash-generation capacity.
Event Date Financial/Deal Size Immediate Market Reaction (Share Price) Investor Concern
Acquisition - Singapore chemical logistics firm June 2023 SGD 38 million -2.3% Integration risk; cash outflow; valuation paid
Partnership - ExxonMobil April 2023 Commercial partnership (contract terms not public) -2.7% Contract margins; operational capacity; execution risk
Full-year financials 2024 Revenue growth +24.26%; Net income CNY 565 million Supportive for valuation Execution of growth and margin retention
  • Investor segmentation: value-oriented holders focus on current profitability (CNY 565M net income) while growth-oriented investors prioritize revenue acceleration (+24.26% in 2024), R&D spend and pipeline M&A to capture higher-margin logistics niches.
  • Sentiment drivers: continued strategic acquisitions, partnerships (e.g., ExxonMobil), and stated R&D/expansion plans tend to offset short-term negative reactions when backed by improving revenue and earnings.
  • Key monitoring items for investors: successful integration of SGD 38M Singapore acquisition, contract performance metrics from the ExxonMobil partnership, and quarterly revenue/earnings delivery vs. guidance.
Milkyway Chemical Supply Chain Service Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Milkyway Chemical Supply Chain Service Co., Ltd. (603713.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.